These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7480390)

  • 21. High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.
    Coppens HJ; Slooff CJ; Paans AM; Wiegman T; Vaalburg W; Korf J
    Biol Psychiatry; 1991 Apr; 29(7):629-34. PubMed ID: 1675892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.
    Nordström AL; Farde L; Halldin C
    Psychopharmacology (Berl); 1993; 110(3):365-7. PubMed ID: 7831432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats.
    Maggos CE; Tsukada H; Kakiuchi T; Nishiyama S; Myers JE; Kreuter J; Schlussman SD; Unterwald EM; Ho A; Kreek MJ
    Neuropsychopharmacology; 1998 Aug; 19(2):146-53. PubMed ID: 9629568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D2-like dopamine receptor density in Tourette syndrome measured by PET.
    Wong DF; Singer HS; Brandt J; Shaya E; Chen C; Brown J; Kimball AW; Gjedde A; Dannals RF; Ravert HT; Wilson PD; Wagner HN
    J Nucl Med; 1997 Aug; 38(8):1243-7. PubMed ID: 9255158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
    Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
    Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.
    Farde L
    Psychopharmacology (Berl); 1992; 107(1):23-9. PubMed ID: 1534178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.
    Iyo M; Nishio M; Itoh T; Fukuda H; Suzuki K; Yamasaki T; Fukui S; Tateno Y
    Psychiatry Res; 1993 Dec; 50(4):217-31. PubMed ID: 8177922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
    Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
    Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography.
    Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
    Life Sci; 2000; 66(25):2455-64. PubMed ID: 10894088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone.
    Ishiwata K; Ogi N; Hayakawa N; Umegaki H; Nagaoka T; Oda K; Toyama H; Endo K; Tanaka A; Senda M
    Nucl Med Biol; 2002 Apr; 29(3):307-16. PubMed ID: 11929700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study.
    Schröder J; Bubeck B; Silvestri S; Demisch S; Sauer H
    Psychiatry Res; 1997 Sep; 75(2):115-23. PubMed ID: 9351493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects.
    Scherer J; Tatsch K; Schwarz J; Oertel WH; Konjarczyk M; Albus M
    Acta Psychiatr Scand; 1994 Oct; 90(4):266-8. PubMed ID: 7831996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competition between 11C-raclopride and endogenous dopamine in Parkinson's disease.
    Ishibashi K; Ishii K; Oda K; Mizusawa H; Ishiwata K
    Nucl Med Commun; 2010 Feb; 31(2):159-66. PubMed ID: 19966595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.
    Martinot JL; Paillère-Martinot ML; Loc'h C; Hardy P; Poirier MF; Mazoyer B; Beaufils B; Mazière B; Allilaire JF; Syrota A
    Br J Psychiatry; 1991 Mar; 158():346-50. PubMed ID: 1827999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
    Nordström AL; Farde L; Wiesel FA; Forslund K; Pauli S; Halldin C; Uppfeldt G
    Biol Psychiatry; 1993 Feb; 33(4):227-35. PubMed ID: 8097114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.